Published in Cancer Weekly, December 7th, 1998
It's a protein called PML. If it works, killer T cells in the body's immune system go into battle against cancerous cells. If it doesn't, the tumor takes over with devastating consequences.
"The master switch controls whether killer cells can recognize the tumor," Dr. Yang Liu, Ohio State University Medical Center in Columbus, Ohio, said in a telephone interview.
PML works by controlling several genes that produce and transport a major histocompatibility complex (MHC) - comprising a peptide and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-12-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.